Shp-2 is an SH2 domain-containing protein tyrosine phosphatase. Although the mechanism
remains to be defined, substantial experimental data suggest that Shp-2 is primarily a …

Shp-2, a widely expressed cytoplasmic tyrosine phosphatase with two SH2 domains, is
believed to participate in signal relay downstream of growth factor receptors. We show here that …

AKT is a key node in the most frequently deregulated signaling network in human cancer.
AZD5363, a novel pyrrolopyrimidine-derived compound, inhibited all AKT isoforms with a …

We have previously shown that activation of extracellular signal-regulated kinase (Erk) by
epidermal growth factor (EGF) treatment was significantly decreased in mouse fibroblast cells …

HeLaHF cells are transformation revertants of cervical cancer HeLa cells and have lost
anchorage-independent growth potential and tumorigenicity. Activation of tumor suppressor(s) …

Although Metformin, a first-line antidiabetic drug, can ameliorate ischemia/reperfusion (I/R)
induced brain damage, but how metformin benefits injured hippocampus and the …

Introduction Activation of the PI3K/AKT pathway is a common phenomenon in cancer due to
multiple mechanisms, including mutation of PI3KCA, loss or mutation of PTEN, or over-…

We identified pyrvinium pamoate, an old anthelminthic medicine, which preferentially
inhibits anchorage-independent growth of cancer cells over anchorage-dependent growth (∼10 …

Large-scale functional genomics approaches are fundamental to the characterization of
mammalian transcriptomes annotated by genome sequencing projects. Although current high-…

The oncogene MDMX, also known as MDM4 is a critical negative regulator of the tumor
suppressor p53 and has been implicated in the initiation and progression of human cancers. …